Calumet Specialty Products Partners (NASDAQ:CLMT – Get Rating) had its price objective hoisted by UBS Group from $18.50 to $19.50 in a research note published on Monday, The Fly reports. Other equities research analysts have also issued research reports about the company. TheStreet raised Calumet Specialty Products Partners from a d+ rating to a c- […]